Members |
targetComponentId |
Administration of therapeutic substance into artery |
Administration via intraarterial route |
Administration of vaccine product containing only Human papillomavirus 9 antigen |
Administration of Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine |
Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens |
Administration of pneumococcal 13-valent conjugate vaccine |
Administrative and indirect care procedures |
Procedure |
Admit hospital emergency NOS |
Emergency hospital admission |
Admit hospital emergency NOS |
Emergency hospital admission |
Admit medical emergency unspecified |
Emergency hospital admission |
Admit medical emergency unspecified |
Emergency hospital admission |
Admit surgical emergency unspecified |
Emergency hospital admission |
Admit surgical emergency unspecified |
Emergency hospital admission |
Adrenal cortex agent |
Adrenal cortex hormone |
Adrenal cortical adenoma - category |
Benign adrenal cortical adenoma (morphologic abnormality) |
Adrenal cortical adenoma, no International Classification of Diseases for Oncology subtype |
Benign adrenal cortical adenoma (morphologic abnormality) |
Adrenal hormone agent |
Adrenal hormone |
Adrenaline 0.5% eye drops |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution |
Adrenaline 1:1000 500micrograms/0.5mL injection |
Adrenaline 1 mg/mL nasal solution |
Adult Kienbock's disease of bilateral lunate |
Progressive avascular necrosis of bilateral lunate bones (disorder) |
Adult disease |
Disease |
Adult periodontitis |
Chronic periodontitis |
Adult rhabdomyoma |
Adult cellular rhabdomyoma (morphologic abnormality) |
Adult type granulosa cell tumor of testis |
Adult type granulosa cell tumor of uncertain behavior (morphologic abnormality) |
Advancement of flap graft |
Reconstruction using local advancement flap (procedure) |
Advancement of mucosa of lip NEC |
Advancement of mucosa of lip (procedure) |
Adverse effect of oral diphosphonate |
Adverse reaction caused by bisphosphonate (disorder) |
Adverse effects NEC |
Adverse reaction (disorder) |
Adverse effects NOS |
Adverse reaction (disorder) |
Adverse health risk due to absence of sink in residence |
Lack of functioning sink in residence (finding) |
Adverse health risk due to absence of toilet in residence |
Lack of functioning toilet in residence |
Adverse health risk due to asbestos in residence |
Asbestos in residence (finding) |
Adverse health risk due to carbon monoxide in residence |
Carbon monoxide in residence |
Adverse health risk due to infestation of residence |
Infestation of place of residence (finding) |
Adverse health risk due to lack of equipment for safe food storage in residence |
Inadequate equipment for safe food storage in residence |
Adverse health risk due to lack of food preparation equipment in residence |
Inadequate food preparation equipment in residence (finding) |
Adverse health risk due to lead in residence |
Lead in residence |
Adverse health risk due to mold in residence |
Mold growth in home (finding) |
Adverse health risk due to radon in residence |
Radon in residence (finding) |
Adverse reaction caused by acidifying agent |
Adverse reaction to drug |
Adverse reaction caused by alkalizing agents |
Adverse reaction to drug |
Adverse reaction caused by carbromal derivative |
Adverse reaction to carbromal |
Adverse reaction caused by drug primarily acting on the smooth and skeletal muscles and respiratory system |
Adverse reaction to drug |
Adverse reaction caused by intravenous diphosphonate |
Adverse reaction caused by bisphosphonate (disorder) |
Adverse reaction caused by liver preparations and other antianemic agents |
Adverse reaction to drug |
Adverse reaction caused by substance |
Adverse reaction (disorder) |
Adverse reaction to CNS depressants and anesthetics |
Adverse reaction to drug |
Adverse reaction to agent affecting blood constituents NOS |
Adverse reaction to drug |
Adverse reaction to agent affecting blood constituents NOS |
Adverse reaction to drug |
Adverse reaction to agents primarily affecting blood constituents |
Adverse reaction to drug |
Adverse reaction to agents primarily affecting blood constituents |
Adverse reaction to drug |
Adverse reaction to antiasthmatic NOS |
Adverse reaction to drug |
Adverse reaction to anticonvulsant and antiparkinsonism drugs NOS |
Adverse reaction to drug |
Adverse reaction to anticonvulsants and anti-parkinsonism drugs |
Adverse reaction to drug |
Adverse reaction to antiparkinsonism drug |
Adverse reaction to drug |
Adverse reaction to antiparkinsonism drugs NOS |
Adverse reaction to drug |
Adverse reaction to bromine compound |
Adverse reaction caused by bromine and/or bromine compound (disorder) |
Adverse reaction to cardiac glycoside |
Adverse reaction to Digitalis glycoside |
Adverse reaction to cardiac glycosides NOS |
Adverse reaction to Digitalis glycoside |
Adverse reaction to central nervous system depressant |
Adverse reaction to drug |
Adverse reaction to central nervous system muscle-tone depressants NOS |
Adverse reaction to drug |
Adverse reaction to clomocycline sodium |
Adverse reaction to clomocycline |
Adverse reaction to clorazepate dipotassium |
Adverse reaction to clorazepate |
Adverse reaction to component of vaccine product containing Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid |
Adverse reaction to COVID-19 vaccine |
Adverse reaction to dental drugs topically applied |
Adverse reaction to drug |
Adverse reaction to drug primarily affecting the autonomic nervous system NOS |
Adverse reaction to drug |
Adverse reaction to drug primarily affecting the cardiovascular system NOS |
Adverse reaction to drug |
Adverse reaction to drug primarily affecting the cardiovascular system NOS |
Adverse reaction to drug |
Adverse reaction to drugs primarily affecting autonomic nervous system |
Adverse reaction to drug |
Adverse reaction to drugs primarily affecting gastrointestinal system |
Adverse reaction to drug |
Adverse reaction to drugs primarily affecting gastrointestinal system |
Adverse reaction to drug |
Adverse reaction to drugs primarily affecting skin and mucous membrane, ophthalmological, otorhinolaryngological and dental drugs |
Adverse reaction to drug |
Adverse reaction to drugs primarily affecting the cardiovascular system |
Adverse reaction to drug |
Adverse reaction to drugs primarily affecting the cardiovascular system |
Adverse reaction to drug |
Adverse reaction to drugs primarily affecting the gastrointestinal system NOS |
Adverse reaction to drug |
Adverse reaction to liver preparations and other antianemic agents NOS |
Adverse reaction to drug |
Adverse reaction to other agent affecting blood constituents |
Adverse reaction to drug |
Adverse reaction to other agent affecting blood constituents NOS |
Adverse reaction to drug |
Adverse reaction to other central nervous system depressants and anesthetics |
Adverse reaction to drug |
Adverse reaction to other drugs primarily affecting the gastrointestinal system |
Adverse reaction to drug |
Adverse reaction to other muscle drugs |
Adverse reaction to drug |
Adverse reaction to other psychotropic agent |
Adverse reaction to drug |
Adverse reaction to other respiratory system drugs |
Adverse reaction to drug |
Adverse reaction to other skin, mucous membrane, ophthalmological, otorhinolaryngological and dental drugs |
Adverse reaction to drug |
Adverse reaction to psychotropic agent |
Adverse reaction to drug |
Adverse reaction to psychotropic agent NOS |
Adverse reaction to drug |
Adverse reaction to skin, mucous membrane, ophthalmological, otorhinolaryngological and dental drugs NOS |
Adverse reaction to drug |
Adverse reaction to sodium cromoglycate |
Adverse reaction to cromoglicic acid |
Adverse reaction to sodium fusidate |
Fusidic acid adverse reaction |
Aeroallergen-induced anaphylaxis |
Anaphylaxis |
Aerobacter aerogenes gastrointestinal tract infection |
Gastrointestinal infection caused by Klebsiella aerogenes |
Aerobacter meningitis |
Meningitis caused by Klebsiella aerogenes |
Aeromonas aquariorum |
Aeromonas dhakensis |
Aeromonas enteropelogenes |
Aeromonas trota |
Aeromonas tructi |
Aeromonas trota |
Aerosol or vapor inhalation for bronchodilation |
Inhaled bronchodilator therapy |
Affect finding |
Mood finding |
Affective seizure |
Focal onset emotional epileptic seizure |
Afipia felis |
Afipia felis |
Agammaglobulinemia |
Congenital agammaglobulinemia |
Aggression caused by ingestible alcohol |
Aggression caused by ethanol (finding) |
Aggressive digital papillary adenoma |
Digital papillary adenocarcinoma |
Agrobacterium radiobacter |
Rhizobium radiobacter (organism) |
Agrobacterium tumefaciens |
Rhizobium radiobacter (organism) |